Unit costs in international economic evaluations: resource costing of the Schizophrenia Outpatient Health Outcomes Study

被引:8
作者
Urdahl, H
Knapp, M
Edgell, ET
Ghandi, G
Haro, JM
机构
[1] Eli Lilly & Co Ltd, European Hlth Outcomes Res, Windlesham GU20 6PH, Surrey, England
[2] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England
[3] London Sch Econ, LSE Hlth & Social Care, Personal Social Serv Res Unit, London, England
[4] Inst Psychiat, Ctr Econ Mental Hlth, London, England
[5] St Joan de Deu SSM, Res & Dev Unit, Barcelona, Spain
关键词
antipsychotic agents; Europe; health-care costs; outpatients; outcome assessment (health care); schizophrenia;
D O I
10.1034/j.1600-0447.107.s416.2.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: We present unit costs corresponding to resource information collected in the Schizophrenia Outpatient Health Outcomes (SOHO) Study. Method: The SOHO study is a 3-year, prospective, observational study of health outcomes associated with antipsychotic treatment in out-patients treated for schizophrenia. The study is being conducted across 10 European countries (Denmark, France, Germany, Greece, Ireland, Italy, the Netherlands, Portugal, Spain and the UK) and includes over 10 800 patients and over 1000 investigators. To identify the best available unit costs of hospital admissions, day care and psychiatrist out-patient visits, a tariff-based approach was used. Results: Unit costs were obtained for nine of the 10 countries and were adjusted to 2000 price levels by consumer price indices and converted to US$ using purchasing power parity rates (and on to C). Conclusion: The paper illustrates the need to balance the search for sound unit costs with pragmatic solutions in the costing of international economic evaluations.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 32 条
[1]  
BALL SG, 1995, BR J CLIN PRACT S, V78, P26
[2]  
BROUWER R, 2001, EC EVALUATION HLTH C, P68
[3]  
Drummond M F, 1992, Int J Technol Assess Health Care, V8, P671
[4]  
DRUMMOND MF, 1987, METHODS EC EVALUATIO, P39
[5]   Economic analysis of tirilazad mesylate for aneurysmal subarachnoid hemorrhage - Economic evaluation of a phase III clinical trial in Europe and Australia [J].
Glick, H ;
Willke, R ;
Polsky, D ;
Llana, T ;
Alves, WM ;
Kassell, N ;
Schulman, K .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1998, 14 (01) :145-160
[6]   The European Schizophrenia Outpatient Health Outcomes (SOHO) study: Rationale, methods and recruitment [J].
Haro, JM ;
Edgell, ET ;
Jones, PB ;
Alonso, J ;
Gavart, S ;
Gregor, KJ ;
Wright, P ;
Knapp, M .
ACTA PSYCHIATRICA SCANDINAVICA, 2003, 107 (03) :222-232
[7]   Utilisation of mental health services and costs of patients with schizophrenia in three areas of Spain [J].
Haro, JM ;
Salvador-Carulla, L ;
Cabasés, J ;
Madoz, V ;
Vázquez-Barquero, JL .
BRITISH JOURNAL OF PSYCHIATRY, 1998, 173 :334-340
[8]   A NOTE ON THE DEPRECIATION OF THE SOCIETAL PERSPECTIVE IN ECONOMIC-EVALUATION OF HEALTH-CARE [J].
JOHANNESSON, M .
HEALTH POLICY, 1995, 33 (01) :59-66
[9]  
Jonsson B, 1996, EUR HEART J, V17, P1001
[10]   Economic evaluation alongside multinational clinical trials - Study considerations for GUSTO IIb [J].
Jonsson, B ;
Weinstein, MC .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1997, 13 (01) :49-58